GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of retatrutide — my 13-week log, condensed into one table — 27 comments in the full submission. View in context.
453
c/retatrutide·submitted 2 years ago by u/zeynep_mbeki

retatrutide — my 13-week log, condensed into one table

Questionbranch of 8 comments

Been lurking in c/sideeffects for about 12 months and finally have something worth posting. Short version: week 74, 1.0mg, and triple agonist is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 13 threads, and the answers split roughly down the middle. What I actually want…

Read the full submission and all 27 comments →

This branch

8 comments, started 2 years ago
u/injection_site_iris97 points·2 years ago·edited

What was the dosing schedule in that arm?

replysharereportpermalink
u/kofi_balogun61 points·2 years ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/tired_ledger_notes45 points·2 years ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink
u/liver_enzyme_liz15 points·2 years ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/niels_lindqvist14 points·2 years ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/farid_molnar48 points·2 years ago·edited

nobody should be giving this to anyone without extensive monitoring

replysharereportpermalink
u/zeynep_mbekiOP28 points·2 years ago

heart rate and dose escalation need actual measurements, not impressions

replysharereportpermalink
u/iman_castellanos33 points·2 years ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.